I. Salmon et al., PROGNOSTIC SCORING IN ADULT ASTROCYTIC TUMORS USING PATIENT AGE, HISTOPATHOLOGICAL GRADE, AND DNA HISTOGRAM TYPE, Journal of neurosurgery, 80(5), 1994, pp. 877-883
High-grade astrocytic tumors constitute the most serious as well as th
e most common group of primary brain tumors. Although several prognost
ic factors have been proposed, little is known about the prognostic va
lue of deoxyribonucleic acid (DNA) ploidy in adult astrocytic tumors.
In a series of 146 adult patients, aged 16 to 82 years, the individual
prognostic values of six variables were studied, namely: tumor histop
athological grade, treatment, patient age, extent of tumor, ploidy lev
el, and DNA histogram type. Cox's proportional hazard model was then a
pplied to the data to ascertain which factors might independently dete
rmine patient survival. Univariate analyses revealed that histopatholo
gical grade, age, and DNA histogram type were very powerful prognostic
factors. The statistical significance of the influence of adjuvant ra
diotherapy and chemotherapy was at a borderline level, and the two rem
aining variables (tumor extent and ploidy level) had no prognostic rel
evance. Multivariate analyses showed that age, histopathological grade
, and DNA histogram type were independent, statistically significant p
rognostic factors. A prognostic score was calculated from Cox's polyno
mial function in which those factors were introduced. The best score c
orresponded to a patient aged 16 years with a hypertriploid low-grade
astrocytoma, while the worst score corresponded to a patient aged 82 y
ears with a diploid high-grade astrocytoma. The worst score:best score
ratio revealed a risk 71 times higher for a bad prognosis. It is conc
luded that patient age, histopathological grade, and DNA histogram typ
e are very powerful prognostic factors for adult astrocytic tumors. A
prognostic score including those factors could be used to characterize
astrocytic tumor aggressiveness presurgically on fine-needle aspirate
s, and to monitor the patient's postsurgical evolution to define the a
ppropriate therapy.